LOURDES LOZANO GONZALEZ: Open Payments
NPI 1396433728 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 39 payments from 14 companies in 2025. Trend: 2023 $96 · 2024 $258 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $183 |
| Otsuka America Pharmaceutical, Inc. | 8 | $137 |
| Neurocrine BioSciences, Inc. | 5 | $113 |
| Lundbeck LLC | 4 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Corium, LLC | 5 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
Products named: REXULTI, VRAYLAR, INGREZZA, HETLIOZ, CAPLYTA, Azstarys, AUSTEDO XR, COBENFY.
Industry payments across FL — which companies pay providers there.
